Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy
Recruiting
Phase 3
Interventional Study
Cardiomyopathies
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 46 (estimated)
- Sponsor
- Tanta University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of current study is to: Evaluate the cardioprotective effects of melatonin in patients with cardiomyopathy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients (≥18 years) with a confirmed diagnosis of cardiomyopathy based on clinical, echocardiographic, or imaging findings. .
* Stable condition on standard cardiomyopathy medications (e.g., ACE inhibitors, beta-blockers).
* Ability to provide informed consent.
Exclusi…
Contacts